$NRX Pharmaceuticals(NRXP.US)$ PR Newswire
RADNOR, Pa., April 1, 2024
Four potential near-term milestones, including data from two clinical trials, an NDA filing and an upcoming share dividend
-- 50% reduction in corporate overhead and 25% reduction in overall net loss in 2023, compared to 2024 with $0.20 per share improvement in negative earnings. Additions to working capital of $8 million in Q1 2024.
-- Company forecasts first commercial revenue in 2024 from sales of ke...

$Tonix Pharmaceuticals(TNXP.US)$ But hear me out! offerings suck in the short run! yes! But what do they do besides dilute! It gives the company cash! Cash that they need for operations! And they didn’t have to go into debt to get the cash! So that helps them be profitable sooner! Now this one in particular! Why now? Just a hunch, but recent filing like the one i posted other day! Maybe they did this to prepare for marketing? So i believe that im going with my hunch and use...

$Save Foods(SVFD.US)$ Touch 10 🤔

$Transcode Therapeutics(RNAZ.US)$ This is on my watch list for tomorrow! hasn’t really reacted to PR from the 16th? Well except for it being shorted to the basement! And as of now FINTEL is showing zero share LTB. The chart is starting to look pretty good. KDJ is severely oversold. RSI 7 & 14 are below 40 approaching relatively oversold! JMO but im liking the way this is setting up. remember to wait for chart to come to you! GL

$BioXcel Therapeutics(BTAI.US)$ going to hit 4 slowly but surely